Table 3.

Estimated ORs and the corresponding confidence intervals for CR rates


Analysis

Group B vs group A (97.5% Cl)

Group D vs group C (97.5% Cl)

Groups B + D vs groups A + C (95% Cl)

Group C vs group A (97.5% Cl)

Group D vs group B (97.5% Cl)

Groups C + D vs groups A + B (95% Cl)
Uni/bivariate       
    OR   1.14 (0.71-1.83)   1.94 (1.20-3.14)   1.48 (1.10-1.99)   0.98 (0.61-1.57)   1.66 (1.02-2.69)   1.27 (0.94-1.70)  
    P  .53   .003   .009   .92   .024   .12  
Multivariate       
    OR   1.11 (0.67-1.83)   1.76 (1.05-2.94)   1.43 (1.05-1.94)   0.98 (0.59-1.60)   1.44 (0.86-2.42)   1.15 (0.84-1.56)  
    P
 
.65
 
.01
 
.025
 
.90
 
.12
 
.38
 

Analysis

Group B vs group A (97.5% Cl)

Group D vs group C (97.5% Cl)

Groups B + D vs groups A + C (95% Cl)

Group C vs group A (97.5% Cl)

Group D vs group B (97.5% Cl)

Groups C + D vs groups A + B (95% Cl)
Uni/bivariate       
    OR   1.14 (0.71-1.83)   1.94 (1.20-3.14)   1.48 (1.10-1.99)   0.98 (0.61-1.57)   1.66 (1.02-2.69)   1.27 (0.94-1.70)  
    P  .53   .003   .009   .92   .024   .12  
Multivariate       
    OR   1.11 (0.67-1.83)   1.76 (1.05-2.94)   1.43 (1.05-1.94)   0.98 (0.59-1.60)   1.44 (0.86-2.42)   1.15 (0.84-1.56)  
    P
 
.65
 
.01
 
.025
 
.90
 
.12
 
.38
 

Multivariate indicates adjustment for cytogenetics (unknown/not done, favorable, intermediate, unfavorable, other), WBC (<5, 5-24.9, 25-99.9, ≥ 100 × 109/L), age (61-65, 66-75, > 75 years), and disease (de novo AML, sAML).

or Create an Account

Close Modal
Close Modal